Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS

NCT02376582 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

HIV/AIDS

Interventions

BIOLOGICAL: DNA
BIOLOGICAL: AIDSVAX B/E

Sponsor

EuroVacc Foundation

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]